TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
FrostPharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
192,935
|
122,923
|
93,128 |
| Financial expenses |
3,912
|
1,987
|
1,415 |
| Earnings before taxes |
4,985
|
9,407
|
18,918 |
| EBITDA |
16,279
|
12,292
|
20,786 |
| Total assets |
263,343
|
85,435
|
66,982 |
| Current assets |
116,229
|
80,086
|
61,445 |
| Current liabilities |
55,021
|
29,372
|
45,255 |
| Equity capital |
120,378
|
28,314
|
20,878 |
| - share capital |
39
|
40
|
39 |
| Employees (average) |
26
|
15
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
33.1%
|
31.2% |
| Turnover per employee |
7,421
|
8,195
|
9,313 |
| Profit as a percentage of turnover |
2.6%
|
7.7%
|
20.3% |
| Return on assets (ROA) |
3.4%
|
13.3%
|
30.4% |
| Current ratio |
211.2%
|
272.7%
|
135.8% |
| Return on equity (ROE) |
4.1%
|
33.2%
|
90.6% |
| Change turnover | |||
| Change turnover % |
31%
|
76% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
50%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.